Literature DB >> 1892325

Mucin structure. The structure and heterogeneity of respiratory mucus glycoproteins.

J K Sheehan1, D J Thornton, M Somerville, I Carlstedt.   

Abstract

Respiratory mucus glycoproteins purified from both "normal" respiratory secretions and sputa of patients with a variety of hypersecretory conditions are high Mr linear molecules adopting a random coil configuration in solution. Studies on their polydispersity show them to have an Mr in the range 3 to 32 x 10(6) and a distribution of length from 200 nm to beyond 10 microns. These macromolecules are fragmented by reduction of intermolecular disulfide bonds into subunits, with Mr approximately 2 x 10(6) and length from 200 to 600 nm. Reduction not only cleaves the mucin molecule but opens, presumably by breaking intramolecular disulfide bonds, cryptic "naked" protein regions. Trypsin digestion of subunits yields high Mr glycopeptides (Mr, 300 to 500,000), presumably by cleavage of the peptide core within the unfolded "naked" protein domains. Respiratory mucus glycoproteins from infected sputum samples are usually heterogeneous in CsCl density gradients, in contrast to those from "normal" tracheobronchial secretions. The former are characterized by the presence of a number of different mucin species, and the basis for the separation of these mucins appears to be the variable presence of sialic acid and sulfate moieties in the oligosaccharide clusters. This heterogeneity may reflect a difference in cellular origin of the mucins and also may be clinically significant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892325     DOI: 10.1164/ajrccm/144.3_pt_2.S4

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  20 in total

1.  Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug.

Authors:  J K Sheehan; M Howard; P S Richardson; T Longwill; D J Thornton
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

Review 2.  Biological interactions of graphene-family nanomaterials: an interdisciplinary review.

Authors:  Vanesa C Sanchez; Ashish Jachak; Robert H Hurt; Agnes B Kane
Journal:  Chem Res Toxicol       Date:  2011-10-21       Impact factor: 3.739

Review 3.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

4.  Sialomucin complex in the rat respiratory tract: a model for its role in epithelial protection.

Authors:  R R McNeer; D Huang; N L Fregien; K L Carraway
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Respiratory mucins: identification of core proteins and glycoforms.

Authors:  D J Thornton; I Carlstedt; M Howard; P L Devine; M R Price; J K Sheehan
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

6.  Binding of Haemophilus influenzae to purified mucins from the human respiratory tract.

Authors:  J Davies; I Carlstedt; A K Nilsson; A Håkansson; H Sabharwal; L van Alphen; M van Ham; C Svanborg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 7.  Structure, biosynthesis, and function of salivary mucins.

Authors:  A M Wu; G Csako; A Herp
Journal:  Mol Cell Biochem       Date:  1994-08-17       Impact factor: 3.396

Review 8.  The Mucus Barrier to Inhaled Gene Therapy.

Authors:  Gregg A Duncan; James Jung; Justin Hanes; Jung Soo Suk
Journal:  Mol Ther       Date:  2016-09-20       Impact factor: 11.454

Review 9.  Olfaction and anosmia in rhinosinusitis.

Authors:  Pamela Dalton
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

10.  Characterization of novel beta-galactosidase activity that contributes to glycoprotein degradation and virulence in Streptococcus pneumoniae.

Authors:  Vanessa S Terra; Karen A Homer; Susmitha G Rao; Peter W Andrew; Hasan Yesilkaya
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.